SCHEMBL30744003

SCHEMBL30744003

Cc1ccc(NC(=O)Nc2ccc(Oc3ccccc3)cc2C)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 2/20 0.58
CXCR2 P25025 1/20 0.53
MEN1 O00255 1/20 0.53
LMNA P02545 1/20 0.53
MAPT P10636 1/20 0.53
KMT2A Q03164 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
CA12 O43570 6/20 0.53
CA1 P00915 6/20 0.53
CA2 P00918 6/20 0.53
CA9 Q16790 6/20 0.53
CDK8 P49336 1/20 0.53
RAB9A P51151 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
NPC1 O15118 2/20 0.52
HPGD P15428 2/20 0.51
MAPK1 P28482 1/20 0.51
GFER P55789 1/20 0.51
MAPK14 Q16539 1/20 0.51
IDO1 P14902 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21295340 1.00 RAF1 (0.58) RAF1CXCR2MEN1LMNAMAPT
SCHEMBL30744018 0.93 RAF1 (0.62) RAF1CXCR2MEN1LMNAMAPT
SCHEMBL21295406 0.93 RAF1 (0.62) RAF1CXCR2MEN1LMNAMAPT
SCHEMBL12994776 0.87 HPGD (0.65) MEN1LMNAMAPTKMT2ANPSR1
SCHEMBL6568524 0.84 CXCR2 (0.77) CXCR2MEN1LMNAMAPTKMT2A
SCHEMBL21295538 0.83 RAF1 (0.58) RAF1MEN1LMNAMAPTKMT2A
SCHEMBL22829287 0.82 PGR (0.59) MAPTRAB9ASMN1; SMN2NPC1MAPK14
SCHEMBL13224739 0.81 MAPK1 (0.59) CXCR2MEN1LMNAMAPTKMT2A
SCHEMBL14384849 0.80 RAF1 (0.56) RAF1MEN1MAPTKMT2ARAB9A
SCHEMBL5853268 0.80 CXCR2 (0.74) CXCR2MEN1LMNAMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111819172-B Triazine derivatives for the treatment of neurotrophin related diseases 阿泽克制药公司 2024-02-06 CN disclosed